GlassScriptPhysician profile
Michael David Austin
NPI 1134199284
$3,329.24
in general payments reported to CMS, 2019-2025
16 companies · $1,164 in 2025
The $1,164 reported for 2025 was more than what 98% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $363 · 2023: $980 · 2024: $822 · 2025: $1,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,961 · Education: $5.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,960.96 |
| Education | $5.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $898.52 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $850.67 | 2022-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $522.50 | 2022-2024 | Jornay Pm |
| Merck Sharp & Dohme LLC | $214.12 | 2022-2025 | Gardasil 9, Vaxneuvance, Enflonsia |
| Collegium Pharmaceutical, INC. | $212.09 | 2025 | Jornay Pm |
| Pfizer INC. | $159.50 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $119.92 | 2024-2025 | |
| Sanofi Pasteur INC. | $70.55 | 2022-2025 | |
| Tris Pharma INC | $67.91 | 2024-2025 | Dyanavel Xr |
| Seqirus USA INC | $43.38 | 2025 | Flucelvax |
| Kowa Pharmaceuticals America, INC. | $43.13 | 2025 | Zoryve |
| Glaxosmithkline, LLC. | $36.36 | 2023-2025 | Bexsero, Penmenvy |
| Vertical Pharmaceuticals, LLC | $31.17 | 2024-2025 | Relexxii |
| Acadia Pharmaceuticals INC | $23.36 | 2025 | Daybue |
| Sobi, INC | $19.16 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $16.90 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Austin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.